UPMC launches cancer drug discovery company August 24, 2021 Auto Bot BioPharma, biopharma nl, cancer, Discovery, drug, hospitals, Immunotherapy, News, UPMC 0 Called Novasenta, the company is focused on the tumor microenvironment and will leverage its machine-learning platform to pinpoint targets for drug development. It aims to launch its first clinical trial by the end of 2023.